Atuzaginstat

Safety and PK data from the Phase I trial of COR588 2:00
Safety and PK data from the Phase I trial of COR588
Michael Detke • 23 Mar 2022
GAIN trial: evidence of target engagement and activity with atuzaginstat in Alzheimer’s disease 19:01
GAIN trial: evidence of target engagement and activity with atuzaginstat in Alzheimer’s disease
Michael Detke • 23 Mar 2022
Phase II/III GAIN trial results: atuzaginstat for disease modification in Alzheimer’s disease 18:06
Phase II/III GAIN trial results: atuzaginstat for disease modification in Alzheimer’s disease
Michael Detke • 16 Nov 2021
The content of VJDementia is intended for healthcare professionals